Buy This Ahead of the Copper Supercycle

Before copper heads any higher, buy this.

View or listen in browser June 3, 2026 Bite Into Profits in the Coming Copper Crunch Dear Subscriber, By Sean Brodrick In mid-April, I wrote a column titled The Perfect Storm for Copper Prices. Turns out I was too pessimistic about copper prices and too optimistic about copper supply.  The coming copper supply/demand crunch is going to be so much worse! I’ve told you that copper is a critical metal, sitting at the center of virtually every major industrial trend shaping the global economy.  It is the metal of electrification, artificial intelligence, power grids, electric vehicles, renewable energy and modern infrastructure. Every one of those trends is growing. The problem is that copper supply is not. According to the International Energy Agency, the current project pipeline of this critical metal is nowhere near sufficient to meet future demand.  If nothing changes, the world could face an implied copper supply shortfall of roughly 30% by 2035.   That’s a picture of a copper supercycle in the making. Traditional commodity markets move through booms and busts.  High prices encourage new production, supply catches up and prices eventually fall.  Copper is increasingly breaking that model because the industry cannot keep up with rising demand. Demand-Side Drivers Demand driver #1: The global power grid overhaul now underway. Utilities around the world are investing hundreds of billions of dollars to modernize aging transmission networks, connect renewable generation projects and expand capacity to meet rising electricity consumption. High-voltage transmission lines, transformers, substations and distribution equipment all require enormous amounts of copper. Demand driver #2: The rapid AI infrastructure buildout. Data centers are becoming some of the largest consumers of electricity on the planet, forcing utilities to build new generation, transmission and backup power systems.  Every new gigawatt of electrical capacity ultimately translates into more copper demand. Demand driver #3: The broader electrification trend.  Wind turbines, solar farms, battery storage systems and electric vehicles all require substantially more copper than their conventional counterparts. Taken together, these trends are expected to push global copper demand from roughly 27 million tonnes in 2024 to approximately 34 million tonnes by 2040. Unfortunately, the supply side of the equation looks far less encouraging. Bringing a copper deposit from discovery to commercial production takes an average of roughly 17 years.  At the same time, average copper ore grades have fallen roughly 40% since 1991.  Miners must move and process significantly more rock to produce the same amount of metal.  That means mining costs are rising. On the exploration side, only about 5% of all copper deposits discovered during the past 35 years were found within the last decade.  In other words, the industry's replacement pipeline is shrinking just as demand is accelerating. The Sulfur Crisis To all this, we can now add more fallout from the blockage of the Strait of Hormuz due to the war with Iran.  Sulfur is produced as a byproduct of oil and gas production. The Persian Gulf states ship sulfur to countries including China, Chile, the Democratic Republic of Congo and Zambia, where it is used for copper mining. The longer the blockade in the Strait drags on, the more we’ll see an extra-hard squeeze on copper supply. The world isn't running out of copper. But if demand continues to rise while supply growth remains constrained, prices don't need an outright shortage to move sharply higher.  They need a market that struggles to keep up. Look at that first chart again. We’re looking at elevated copper prices for YEARS. How to Play It I’ll make the same recommendation that I did in April: The Global X Copper Miners ETF (COPX).  It holds a global basket of miners, including Freeport-McMoRan, BHP, Southern Copper and Zijin. Since miners are leveraged to the metal, this can amplify gains.  The fund has an expense ratio of 0.65%.   You can see COPX zigzagging since I mentioned it in April.  Now, it finally seems about to break out. Sure looks to me like copper and copper miners have a bright and shiny future.  You should pick some up before the blast-off really begins. All the best, Sean P.S. In case you missed it, my colleague Chris Graebe held a special event yesterday showcasing a SpaceX partner that, too, is pre-IPO. But you can actually buy this one before it does. Watch the replay here. Never Miss a Trade Again Download the Weiss Ratings App Follow us:   11780 US Highway 1, Palm Beach Gardens, FL 33408-3080, USA Would you like to edit your e-mail notification preferences or unsubscribe from our mailing list? Copyright © 2026 Weiss Ratings. All rights reserved.

The SpaceX filing just happened. You've got days.

21 banks are preparing to underwrite what could be the biggest IPO in Wall Street history  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Read online Elon’s filing for the SpaceX IPO just hit the mainstream news… And everyone is wondering how I called it… almost to the exact day being reported. Well… I met Elon Musk face to face. At a private gathering of the world's financial elite, I was one of just two people selected to speak with him personally. That conversation — combined with three years studying patterns at CIA headquarters — is why my SpaceX prediction was dead on accurate. And while the mainstream media was playing catch-up... I had already helped nearly 15,000 Main Street Americans discover the "backdoor" way to stake a claim pre-IPO. Now the stakes are even higher. The filing just happened. 21 banks — including JPMorgan, Goldman Sachs, and Morgan Stanley — are preparing to underwrite what they're calling "Project Apex." The framework for the biggest IPO in Wall Street history. Everyone is now looking at June. So here’s what that means for you and your money… You just got a gift. A few more days to position yourself before the biggest gains are gobbled up by Wall Street insiders. Once the roadshow kicks off... once the media frenzy begins... once millions of investors scramble to get in... The window slams shut. But right now — today — you still have time. I'm giving away my top pre-IPO SpaceX pick completely free. No credit card. No email required. But I wouldn't wait. June is coming fast. Click here to get my FREE SpaceX pre-IPO recommendation now. Yours for peace, prosperity, and liberty, AEIOU, Dr. Mark Skousen Macroeconomic Strategist, The Oxford Club P.S. I've already helped nearly 15,000 everyday investors get positioned before this historic IPO. Now it's your turn. But the window is closing fast. Get my free recommendation here… before it's too late. This Month's Exclusive Content These Stocks Could Be the Biggest Winners of the 2026 Midterms Submitted by Chris Markoch. Article Posted: 5/18/2026. Key Points Defense, healthcare, and financial stocks are showing strength ahead of the U.S. midterm elections. Investors are focusing on policy-sensitive sectors as markets price in shifting congressional power dynamics. Historical data suggests midterm election years can create outsized opportunities in select sectors. Special Report: Before SpaceX goes public, watch this tiny supplier closely (From Weiss Ratings) The midterm elections in the United States are still six months away, but there are already many stocks getting a boost. Elections have consequences for policy initiatives, and that’s especially true in midterm years. S&P Dow Jones research shows that for mid- and small-cap companies, cross-sector effects in congressional election months were greater than average 83% of the time in months with only congressional elections, outpacing presidential election months at 67%. This suggests midterms may actually be more disruptive to sector relationships than presidential elections, even if they receive less attention. Goldman Sachs just told you what to buy (most people missed it) (Ad) Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - not chips, not funding, but power. Demand is growing 15% per year and the grid can't keep up. One small company makes the exact equipment these data centers need. They're sitting on $1.5 billion in orders, their hardware is already inside Musk's Colossus, and the stock still trades like a name nobody's heard of. Analyst Dylan Jovine is releasing the ticker for free. See the stock positioned to solve AI's biggest power crisis The reason is obvious, and it is becoming more pronounced as the extremes of both parties hold greater sway. Specifically, this November, if the party out of power wins control of both houses of Congress, investors should expect a very different set of policy priorities. Conversely, if the status quo remains, there will be more of what’s been in place over the last two years. Politics Matters Less Than the Macro Story But that’s not necessarily what the markets are showing. That’s a good reminder that the stock market is not the economy, but that economic fundamentals shape the market more than election outcomes do. With the midterm elections looming, issues like inflation, GDP growth, and geopolitical tensions may carry more weight for investors. This is why it’s always important to remember that markets are forward-looking. Short-term momentum plays a role, for sure. But in many cases, when investors see a stock or an entire sector moving higher or lower, they should take out their crystal ball, because that’s what the big money is doing. Before stepping away for summer activities, it may be time to consider taking, or adding to, a position in these securities. LMT and RTX Don't Have to Be an Either/Or Decision Even if the kinetic part of the conflict with Iran is over, the first half of 2026 has illustrated the likelihood that more will be spent on defense. Investors often frame Lockheed Martin (NYSE: LMT) and RTX (NYSE: RTX) as an either/or choice. However, at a time when the Pentagon is accelerating toward autonomous systems and AI-powered warfare, the case for holding both is worth considering. The proposed fiscal 2026 (FY2026) Defense Department budget allocates over $13 billion to autonomy and AI initiatives alone. This is a signal that the spending battle isn't just about legacy procurement. Both companies are positioning for this transition, but through different paths. Lockheed's argument centers on upgrading legacy hardware into next-generation capability. The company is embedding AI and autonomous capabilities into its world-leading platforms, making them intelligent nodes in a networked battlefield. It is also developing advanced technologies, including hypersonics and directed-energy weapons. The approach is slower, but it carries lower risk because the company’s existing technology is deeply embedded in government contracts. RTX is moving faster on autonomy. The company partnered with Shield AI to field the first operational weapon powered by Networked Collaborative Autonomy, integrating autonomous capabilities into loitering munitions and sensors—fully funded by the companies themselves, without government investment. That private-capital commitment signals real conviction in where defense spending is heading. Politically, defense budgets don't contract dramatically after midterm power shifts. Either outcome in November keeps the contracts already on the books intact. The question isn't which company wins the next-gen transition, but how much of the pie they get. Nobody Agrees on This Midterm Play—Which Makes It Worth Watching Healthcare is the third rail of American politics, and every two years the market has to price in what might actually change. But it’s that tension that creates an opportunity for broad exposure in the Health Care Select SPDR Fund (NYSEARCA: XLV). In midterm election years from 1994 to 2024, healthcare outperformed the S&P 500 by an average of nearly 17%. And yet the sector is currently lagging. XLV is down about 5% year to date, weighed down by drug-pricing uncertainty and managed-care earnings pressure. That said, the demographic case is unambiguous. An aging population means structural increases in demand for healthcare products and services, ranging from pharmaceuticals and managed care to medical devices and biotech. That demand doesn't change based on election outcomes. But the political case is messy. Healthcare costs figured prominently in the first year of Trump's second term and will likely play an even bigger role heading into the 2026 midterms, with tax legislation cutting more than $1 trillion from health insurance spending over a decade—mostly Medicaid—to help fund broader tax cuts. ACA subsidy reinstatement and drug-pricing reform are live issues on both sides of the aisle. That gap between historical patterns and current performance sets up the opportunity. Healthcare costs are a genuine budget problem for both parties. That means neither side can afford to crater the sector, only reshape it. For an investor with a six-month horizon and tolerance for policy noise, the entry point today may look a lot better come November. Agnostic to Interest Rates? Not Quite. Interest rates will be on the front burner between now and the midterm elections. The CME FedWatch Tool now puts the odds of an October interest rate hike at around 21%. That’s driving interest in funds such as the Financial Select Sector SPDR Fund (NYSEARCA: XLF). That follows conventional wisdom: rising rates are good for banks, while falling rates compress margins. That framework is mostly right. Financial stocks aren't truly agnostic, but they're less about the absolute level and more about the spread. As the 10-year Treasury yield curve normalizes, net interest margins should improve for regional lenders, while digital asset integration and agentic AI adoption are opening new avenues for efficiency and revenue for larger institutions. It also partly explains XLF's rough start in 2026. The fund is trading nearly 13% below its 52-week high, and financials have been the S&P 500's worst-performing sector year to date. That said, financials' sensitivity to policy may matter more than rates as we approach November. From the onset of Trump's second term, expectations ran high for additional financial deregulation (i.e., a further dismantling of Dodd-Frank provisions and the CFPB). A Democratic House takeover puts tighter capital requirements and reinstated consumer protections back on the table. This ad is sent on behalf of The Oxford Club. 105 W Monument St, Baltimore, Maryland 21201. If you would like to optout from receiving offers from The Oxford Club please click here .   Update your email preferences or unsubscribe here © 2026 Ticker Talk 345 N Reid Place, Suite 620 Sioux Falls, SD 57106, United States Terms of Service

🔴 New Trade Alert: Watch a Money Press on RDDT get built from scratch

Hi , Want to see exactly how a Money Press works — step by step, in real time?   I just recorded myself opening a brand-new trade on Reddit (RDDT), and I'm sharing it with you for free.   In the video, you'll see: ✅ Why I chose Reddit and why I likes it right now ✅ How to set up the trade in the same order ✅ The actual fill prices, dollar amounts, and math behind the trade ✅ How this one position could generate income week after week through August   No fluff. No theory. Just a real trade, placed live, with full transparency.   👉 [Watch the Free Video →]   Enjoy!   Preston "The Pirate" James Traders Edge Network   P.S. This is just one of the Money Press trades running inside WOW Insider — across sectors like cybersecurity, defense, and more. Come join us for more trades and more fun.   Unsubscribe Traders Edge Network 8180 South 700 East Suite 210 Sandy, Utah 84070 United States (801) 733-4190

The one stock that wins no matter how old America gets

73 million boomers, $25B in revenue, and a demand curve that doesn't quit.  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

June 02, 2026 Stryker (SYK): The Demographic Trade Nobody Can Cancel When 73 million people need new knees, someone has to build them. Sponsored First a note from Weiss Ratings Dear Reader, Would you like to know how to tap into the $1.75 trillion SpaceX IPO windfall ... But without buying a single SpaceX share? This has nothing to do with options ... ETFs ... or anything like that ... Yet it could hand you the chance to collect bigger gains than most people could ever dream of ... Click here to see how. Eliza Lasky Weiss Ratings FEATURED Stryker (SYK): The Demographic Trade Nobody Can Cancel Most investment themes come with an expiration date. Rate cycles turn. Consumer trends reverse. A competitor shows up with a better product. You know the drill. The aging of America is not one of those themes. What the Scoreboard Says Stryker posted $25.1 billion in full-year 2025 revenue – up 11.2% from 2024. Orthopedics alone came in at $9.5 billion for the year. MedSurg and Neurotechnology added another $15.6 billion, a 15.7% jump year over year. Net earnings hit $3.2 billion, a 55.5% increase versus the prior year. That's not a fluke quarter. That's a machine running at altitude. Management is guiding for 8% to 9.5% full-year sales growth in 2026. Analyst consensus EPS forecast for next year sits around $12.74, compared to $8.49 last year. The stock has pulled back roughly 24% over the past twelve months – which is either a warning sign or a setup, depending on how you think about the next decade. I lean toward setup. Here's why. The Demand That Doesn't Negotiate Baby boomers – born between 1946 and 1964 – number roughly 73 million in the U.S. The oldest are approaching 80. The youngest are pushing 60. By 2030, every single one of them will be 65 or older, meaning one in five Americans will be a senior citizen. That's not a projection with a lot of wiggle room. It's arithmetic. Aging drives orthopedic volume in a way that's almost mechanical. Joints wear out. Cartilage thins. Hips and knees that got someone through 40 years of work, exercise, and general living eventually need to be replaced. Studies consistently tie roughly 20% of healthcare spending growth directly to population aging. That money flows somewhere – and a big chunk of it flows through surgical suites, and right into Stryker's revenue line. Slight tangent, but it matters: this isn't just a U.S. story. Global aging trends are accelerating across Europe, Japan, and parts of Southeast Asia simultaneously. Stryker operates internationally, which means the addressable market for orthopedic hardware isn't contracting anytime soon. Sponsored Most $5 Stocks Are Noise. These 5 Are Different There's a reason most investors avoid stocks under $5. But not every company at this level fits that stereotype. These five Nasdaq names are tied to real markets and long-term trends. They are still early, still developing, and not widely followed, which may be exactly why they stand out. Learn More How the Business Actually Works Stryker makes implants, surgical instruments, robotic surgery systems (the Mako platform), and hospital equipment. The orthopedic segment – hips, knees, trauma fixation – is the part of the business most directly tied to the boomer tailwind. But the MedSurg and Neurotechnology side, which covers endoscopy, medical equipment, and neurovascular products, has been growing faster and now accounts for the majority of total revenue. The Mako robotic surgery platform deserves a mention here. It's a competitive moat. Surgeons trained on Mako tend to stay on Mako. Hospital systems that invest in the platform don't switch. That kind of installed-base stickiness is what makes Stryker's recurring revenue more durable than a lot of med-tech peers. Stryker also put roughly $1.62 billion into R&D in 2025 and completed approximately $5 billion in acquisitions – including Inari Medical, which expands its vascular portfolio into venous thromboembolism treatment. The company is not standing still while demographics do the heavy lifting. The Numbers Worth Tracking FY2025 revenue: $25.1B (+11.2% YoY) Orthopedics segment: $9.5B (+4.3% YoY; organic growth 9.3%) MedSurg & Neurotechnology: $15.6B (+15.7% YoY) Gross profit margin: ~63.9% (FY2025) Net earnings: $3.2B (+55.5% YoY) R&D spend: $1.62B Cash and equivalents: $4.1B Total debt: $15.9B (elevated post-acquisition) 2026 sales guidance: +8% to +9.5% 3-year forward revenue CAGR (analyst consensus): ~7.7–7.9% The debt load is real and worth watching. Stryker issued $3.0 billion in new senior notes in 2025 and carries $15.9 billion in total debt. That's the cost of being aggressive on M&A. It's manageable at current cash flow levels – but it does mean the balance sheet is not pristine right now. Bull, Base, Bear Bull: Demographics compound for 10+ years, Mako adoption accelerates, Inari integration adds a high-growth vascular leg, margins expand, EPS hits $14+ by 2028. Stock re-rates toward $400. Base: Mid-single-digit organic growth continues, debt gets steadily paid down, earnings grow 12–15% annually in line with consensus. Stock trades in the $310–$360 range over the next 18 months. Bear: Hospital capex freezes in a recession, pricing pressure intensifies, debt servicing costs bite into free cash flow, and the stock stays range-bound or drifts lower. The demographic thesis is intact – but valuation doesn't expand. Cheap Investor Scorecard Demographic tailwind: durable and multi-decade – check Revenue growth consistency: 10%+ over 3 years – check Gross margins above 63%: competitive moat confirmed – check Robotic surgery installed base (Mako): high switching costs – check Diversified beyond orthopedics (MedSurg, Vascular): check R&D investment: $1.62B annually – check Dividend payer: $1.28B paid in 2025 – check Debt load post-Inari acquisition: elevated – monitor 2026 guidance: 8–9.5% growth, raised mid-year – check Stock down ~24% from highs: potential entry window – check Here's where I land on this. If you believe 73 million aging Americans need more orthopedic procedures over the next 10 to 15 years – and the data says they will – then Stryker is one of the cleanest expressions of that trade in public markets. The pullback brings the entry point to a more interesting place. The debt is worth watching. But the demand curve? That one's already written. The question isn't whether the trend is real. It's whether you're positioned before the wave or chasing it. – The Cheap Investor This content is for informational purposes only and should not be considered financial advice. Investing involves risk. The Cheap Investor is a publication of Investing Media Solutions, LLC. To view our full policies: Disclaimer | Privacy Policy | Terms & Conditions Update your email preferences or unsubscribe here © 2026 The Cheap Investor 203 N La Salle Suite 2100 Chicago , Illinois 60601, United States Powered by beehiiv Terms of Service

FINAL: How 2 Unique Price Patterns Have Been Hitting Doubles with Same-Week Options Trades

They laughed, until they saw how it works...

Hey Trader, Tap here to watch your replay of the Quick Options Doublers event... Last week, the CHWY May (Week 5) 20.5 Calls were entered at $0.94 and closed at $1.88 for a +100.00% gain and +$940. And just before that… The DAL May Week 5 77 Calls were entered at $2.86 and closed at $5.75 for a +101.05% gain and +$867. Here are a few more recent winners from the strategy... +100.00% on CHWY +101.05% on DAL +100.00% on META +100.00% on DELL +22.64% on TTD +8.96% on EBAY   (past performance does not guarantee future results, allocating up to $1,000 per trade) That winning trade was triggered by a very specific system. A system designed to do one thing extremely well. Find short bursts of explosive price movement in highly liquid stocks using same-week options, then extract fast, decisive gains before the market has time to change its mind. This is not about predicting where the market will be next month. It is not about falling in love with a stock. And it is definitely not about staring at screens all day. This is about precision timing, controlled risk, and repeatable execution. Why We Love "Quick Options Doublers" for 2026... We are entering a market environment defined by constant news flow. Earnings surprises. Rate speculation. Sector rotation. Powerful headlines. That means sharp rallies and violent sell-offs are no longer rare events. They are the norm. Quick Options Doublers was built specifically for this kind of market. It does not care whether stocks are rising or falling. It is designed to capitalize on movement, not direction. Bullish setups. Bearish setups. Same rules. Same timing. Same structure. And when the conditions line up, the payoff can be fast and dramatic. Here's another real-world example... On March 24, 2026,  DELL triggered a bullish setup. Nothing fancy. No guesswork. Just a clean signal on the daily chart. The DELL March Week 4 172.5 Calls were entered at $6.15. One day later, they were closed at $12.30. That is a +100 percent gain. A $615 return on a single contract. And that trade followed the same framework you will learn inside this strategy. Most traders think faster charts mean faster profits. They obsess over five-minute candles. They chase breakouts. They overreact to noise. And the result is usually the same. Late entries. Emotional exits. Inconsistent results. Quick Options Doublers takes the opposite approach. We start with the daily chart. Why? Because daily charts filter out noise. They eliminate fake-outs. And they reveal the kind of price behavior that actually matters. New trades only trigger on Tuesdays and Wednesdays. Alerts are sent between 3:00 and 3:45 PM ET. Entries are made in the final hour of the session. This is not random. It's intentional. Quick Options Doublers focuses on price action patterns that tend to precede short-term acceleration. For long trades, we want to see... Consecutive higher closes. Back-to-back green bars. Clean price behavior that signals pressure building beneath the surface. For short trades, we look for the opposite. Weakness. Deterioration. Price structures that historically precede fast downside movement. The other settings are proprietary. But when you join, you'll get them all. The scans. The chart settings. The triggers. If a stock performs well with this strategy, we are not afraid to trade it again. That is why you see names like Citi and ConocoPhillips appear repeatedly in the trade history. Consistency matters! Also... Every Quick Options Doublers trade uses same-week options. Why? Because leverage matters. Since 2020, the average contract price has been approximately $2.14. That makes this approach accessible to both small and large accounts. And it is exactly why we have seen countless +100 percent winners over time. You are not waiting weeks for a move to develop. You are targeting fast, decisive follow-through.   Not Every Trade Will Be a Winner. Let’s be very clear. This is real trading. There will be losses. For example, the SHOP March Week 4 81 Calls were entered at $1.41 and closed at $0.70. That was a -50.35 percent loss. And we show it. Because transparency matters. Risk is controlled by design. Each trade has... A predefined profit target. A predefined stop. A strict time stop of three trading days. Sometimes trades are closed early for partial gains. Sometimes they gap beyond the target. Sometimes they are stopped out. That is how a real system operates. This is not day trading. This is not scalping. This is not guesswork. You are not glued to your screen. You are not reacting to every tick. In fact, the total time commitment is minimal. Most traders spend less than 15 minutes per week managing this strategy. That is it. How can you get started? Until midnight tonight, a small group of traders will be allowed to join Quick Options Doublers and receive real-time trade alerts when a new setup appears. Here's what's included: - 12 Months of Quick Options Doublers Trade Alerts Real-time alerts delivered via email and mobile. - Average of 6 to 10 trades per month. Entries sent in the final hour on Tuesdays and Wednesdays. - Settings and Rules Sheet Every parameter. Every rule. Nothing left out. - Weekly Video Updates  My thoughts on the broad market and top performing strategies - Unlimited Email Access Ask questions. Get clarification. Interact directly with our research team. BONUS: Deep-Dive Strategy Session An HD training video that walks through the exact system logic and chart examples step by step. What's the Investment? The regular value of this package is $3,564. That is based on a $297 monthly list price. But today, I'm dropping the price down to just $1,497, and the first 27 traders will get something extra. You will receive an additional year for FREE! That's 24 months of alerts, training, and support. The price for everything is $1,497. And if you use promo code DOUBLE1000, you take $1,000 off instantly. Which means you will get this entire 2 year trading package for just $497. Go here to activate your trade alerts and $1,000 instant gift... Just one trade from the track record could have easily covered that! Final Reminder This offer expires at midnight and only 27 spots are available.   If you want a structured, rules-based way to trade same-week options without guessing, overtrading, or living in front of a screen, this is your opportunity. Tap here to claim your trades and bonuses... Trade well, Price Headley Founder and CEO, BigTrends P.S. Grab your trades before midnight tonight, there are only 27 spots available... Yes, Show Me How to Find "Double Confirmed" Options Trades That Have Been Doubling in Days... The information above reflects the track record of each of BigTrends.com’s trade alerts for this product during the period of time identified. Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don’t trade with money you can’t afford to lose. BigTrends.com does not represent that any account will or is likely to achieve profits or losses similar to those discussed. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed are for illustrative purposes only and not to be construed as specific advisory recommendations. Information shown is intended for informational purposes only. BigTrends.com is a publisher and the information provided through its products and services are for informational purposes only. To the extent any such information is deemed to be advice, such information is impersonal and not tailored to the investment needs of any specific person. BigTrends.com is not restricted from owning individual securities or options. In addition, certain BigTrends.com affiliates and employees may, from time to time, have long and short positions in, or buy or sell the securities, or derivatives thereof, of companies mentioned in BigTrends.com’s products and may take positions inconsistent with the views expressed by BigTrends.com. Unsubscribe HIA Corp. 201 West Vine Street Lexington, Kentucky 40507 United States